Calfornia [US], August 29 (ANI): According to a UC Davis Health study, treating skin lesions and symptoms of monkeypox with the antiviral tecovirimat seems to be both safe and effective. The research is among the earliest to evaluate and document the effects of using this antiviral drug to treat patients with monkeypox.
Calfornia [US], August 29 (ANI): According to a UC Davis Health study, treating skin lesions and symptoms of monkeypox with the antiviral tecovirimat seems to be both safe and effective. The research is among the earliest to evaluate and document the effects of using this antiviral drug to treat patients with monkeypox.
\
\
\
\
